174 related articles for article (PubMed ID: 22309979)
1. Noladin ether, a putative endocannabinoid, enhances motivation to eat after acute systemic administration in rats.
Jones EK; Kirkham TC
Br J Pharmacol; 2012 Jul; 166(6):1815-21. PubMed ID: 22309979
[TBL] [Abstract][Full Text] [Related]
2. Stimulation of accumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats.
Deshmukh RR; Sharma PL
Pharmacol Res; 2012 Sep; 66(3):276-82. PubMed ID: 22728691
[TBL] [Abstract][Full Text] [Related]
3. Effects of the endocannabinoid noladin ether on body weight, food consumption, locomotor activity, and cognitive index in mice.
Avraham Y; Menachem AB; Okun A; Zlotarav O; Abel N; Mechoulam R; Berry EM
Brain Res Bull; 2005 Mar; 65(2):117-23. PubMed ID: 15763177
[TBL] [Abstract][Full Text] [Related]
4. Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB1/CB2 G(i/o) linked receptor.
Duncan M; Millns P; Smart D; Wright JE; Kendall DA; Ralevic V
Br J Pharmacol; 2004 Jun; 142(3):509-18. PubMed ID: 15148262
[TBL] [Abstract][Full Text] [Related]
5. Activating parabrachial cannabinoid CB1 receptors selectively stimulates feeding of palatable foods in rats.
DiPatrizio NV; Simansky KJ
J Neurosci; 2008 Sep; 28(39):9702-9. PubMed ID: 18815256
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid.
Laine K; Järvinen K; Mechoulam R; Breuer A; Järvinen T
Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3216-22. PubMed ID: 12356827
[TBL] [Abstract][Full Text] [Related]
7. Noladin ether acts on trabecular meshwork cannabinoid (CB1) receptors to enhance aqueous humor outflow facility.
Njie YF; Kumar A; Qiao Z; Zhong L; Song ZH
Invest Ophthalmol Vis Sci; 2006 May; 47(5):1999-2005. PubMed ID: 16639008
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of endocannabinoids on [(3)H]-GABA uptake in the rat globus pallidus.
Venderova K; Brown TM; Brotchie JM
Exp Neurol; 2005 Jul; 194(1):284-7. PubMed ID: 15899265
[TBL] [Abstract][Full Text] [Related]
9. Delta9-THC induced hyperphagia and tolerance assessment: interactions between the CB1 receptor agonist delta9-THC and the CB1 receptor antagonist SR-141716 (rimonabant) in rats.
Järbe TU; DiPatrizio NV
Behav Pharmacol; 2005 Sep; 16(5-6):373-80. PubMed ID: 16148441
[TBL] [Abstract][Full Text] [Related]
10. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
Gómez R; Navarro M; Ferrer B; Trigo JM; Bilbao A; Del Arco I; Cippitelli A; Nava F; Piomelli D; Rodríguez de Fonseca F
J Neurosci; 2002 Nov; 22(21):9612-7. PubMed ID: 12417686
[TBL] [Abstract][Full Text] [Related]
11. Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice.
Avraham Y; Israeli E; Gabbay E; Okun A; Zolotarev O; Silberman I; Ganzburg V; Dagon Y; Magen I; Vorobia L; Pappo O; Mechoulam R; Ilan Y; Berry EM
Neurobiol Dis; 2006 Jan; 21(1):237-45. PubMed ID: 16102970
[TBL] [Abstract][Full Text] [Related]
12. Differential modulation of endogenous cannabinoid CB1 and CB2 receptors in spontaneous and splice variants of ghrelin-induced food intake in conscious rats.
Ting CH; Chi CW; Li CP; Chen CY
Nutrition; 2015 Jan; 31(1):230-5. PubMed ID: 25466669
[TBL] [Abstract][Full Text] [Related]
13. Role of cannabinoid CB1 receptors on macronutrient selection and satiety in rats.
Escartín-Pérez RE; Cendejas-Trejo NM; Cruz-Martínez AM; González-Hernández B; Mancilla-Díaz JM; Florán-Garduño B
Physiol Behav; 2009 Mar; 96(4-5):646-50. PubMed ID: 19150453
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats.
Scherma M; Fattore L; Satta V; Businco F; Pigliacampo B; Goldberg SR; Dessi C; Fratta W; Fadda P
Br J Pharmacol; 2013 Jun; 169(4):820-33. PubMed ID: 23072421
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol.
Kirkham TC; Williams CM; Fezza F; Di Marzo V
Br J Pharmacol; 2002 Jun; 136(4):550-7. PubMed ID: 12055133
[TBL] [Abstract][Full Text] [Related]
16. Effects of cannabinoid drugs on the reinforcing properties of food in gestationally undernourished rats.
Wakley AA; Rasmussen EB
Pharmacol Biochem Behav; 2009 Nov; 94(1):30-6. PubMed ID: 19602424
[TBL] [Abstract][Full Text] [Related]
17. Photoperiodic changes in endocannabinoid levels and energetic responses to altered signalling at CB1 receptors in Siberian hamsters.
Ho JM; Smith NS; Adams SA; Bradshaw HB; Demas GE
J Neuroendocrinol; 2012 Jul; 24(7):1030-9. PubMed ID: 22420341
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus.
Soria-Gómez E; Matias I; Rueda-Orozco PE; Cisneros M; Petrosino S; Navarro L; Di Marzo V; Prospéro-García O
Br J Pharmacol; 2007 Aug; 151(7):1109-16. PubMed ID: 17549045
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of two cannabinoid receptor agonists on progressive ratio responding for food and free-feeding in rats.
Higgs S; Barber DJ; Cooper AJ; Terry P
Behav Pharmacol; 2005 Sep; 16(5-6):389-93. PubMed ID: 16148443
[TBL] [Abstract][Full Text] [Related]
20. CB1 cannabinoid receptor-mediated changes of trabecular meshwork cellular properties.
Kumar A; Song ZH
Mol Vis; 2006 Apr; 12():290-7. PubMed ID: 16617296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
